Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CYP2E1 encodes a member of the cytochrome P450 superfamily of enzymes. Additionally we are shipping Cytochrome P450, Family 2, Subfamily E, Polypeptide 1 Kits (44) and Cytochrome P450, Family 2, Subfamily E, Polypeptide 1 Proteins (22) and many more products for this protein.
Showing 10 out of 180 products:
Mouse (Murine) Polyclonal CYP2E1 Primary Antibody for IHC (p), WB - ABIN3044118
Fan, Jiang, Wang, Tan, Zeng, Wang, Chen, Qu, Gonzalez, Huang, Bi: Wuzhi tablet (Schisandra Sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53/p21 pathways. in Drug metabolism and disposition: the biological fate of chemicals 2014
Show all 3 references for 3044118
Human Polyclonal CYP2E1 Primary Antibody for IHC (p), WB - ABIN3043821
Jiang, Fan, Wang, Chen, Zeng, Tan, Gonzalez, Huang, Bi: Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration. in Toxicological sciences : an official journal of the Society of Toxicology 2014
Show all 3 references for 3043821
Human Polyclonal CYP2E1 Primary Antibody for WB - ABIN3043000
Chen, Sun, Han, Peng, Li, Liu, Lv, Liu, Zhou, Sun: Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significantly correlated with cytochrome P450 suppression. in World journal of gastroenterology 2009
Show all 3 references for 3043000
Human Polyclonal CYP2E1 Primary Antibody for IF, IHC - ABIN1534388
Umeno, McBride, Yang, Gelboin, Gonzalez: Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. in Biochemistry 1989
Show all 2 references for 1534388
Human Polyclonal CYP2E1 Primary Antibody for IHC, IHC (p) - ABIN4302106
Hou, Bukong, Kodys, Szabo: Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cells. in Alcoholism, clinical and experimental research 2013
Human Polyclonal CYP2E1 Primary Antibody for IHC, IHC (p) - ABIN4302104
Fagerberg, Hallström, Oksvold, Kampf, Djureinovic, Odeberg, Habuka, Tahmasebpoor, Danielsson, Edlund, Asplund, Sjöstedt, Lundberg, Szigyarto, Skogs, Takanen, Berling, Tegel, Mulder, Nilsson, Schwenk et al.: Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. ... in Molecular & cellular proteomics : MCP 2014
Cow (Bovine) Polyclonal CYP2E1 Primary Antibody for WB - ABIN2776801
Dey, Kessova, Cederbaum: Decreased protein and mRNA expression of ER stress proteins GRP78 and GRP94 in HepG2 cells over-expressing CYP2E1. in Archives of biochemistry and biophysics 2006
The localization of CYP1A2 (show CYP1A2 Antibodies), CYP2B4 and CYP2E1 within the ER was determined by partial membrane solubilization with Brij 98
Data suggest a homeostatic, gene dosage-insensitive regulation of CYP2E1 expression by unknown gene dosage compensation mechanisms.
Data suggest that microRNA-214-3p (but not microRNA-942-5p) suppresses expression of CYP2E1 in hepatocytes; microRNA-214-3p interacts with two binding sites located in protein coding region of CYP2E1 mRNA. (CYP2E1 = cytochrome P450 (show CYP Antibodies) family 2 subfamily E member 1)
The synergistic effect of VK2 and EtOH was also observed in QGY-7703 cells, which also express CYP2E1. However, in HepG2 cells, which do not express CYP2E1, the synergistic effect of VK2 and EtOH was not observed
The results suggest that there is no evidence for a major role of CYP2E1 polymorphism in liver carcinogenesis, but do not rule out the possibility in certain cases. [meta-analysis]
The CYP2E1-PPARalpha (show PPARA Antibodies) axis may play a role in ethanol-induced neurotoxicity via the alteration of the genes related with synaptic function
Results demonstrated that CYP2E1*5B and CYP2E1*6 minor alleles play a role in the development of sporadic colorectal neoplasms.
This meta-analysis suggests that there is an increased risk of antituberculosis drug-induced hepatotoxicity in individuals carrying the C1/C1 genotype of the CYP2E1 RsaI/PstI (show SPINK1 Antibodies) polymorphism; however, no association was found for the DraI polymorphism
NS5A contributes to reactive oxygen species production by activating expression of NADPH (show NQO1 Antibodies) oxidases 1 and 4 as well as cytochrome P450 2E1.
This meta-analysis suggests that the CYP2E1 polymorphisms contributed to the susceptibility of nasopharyngeal carcinoma, especially in Asian populations.
Study indicate that ALDH2 (show ALDH2 Antibodies) Glu487Lys and CYP4502E1 polymorphisms could be risk factors for the development of gastric cancer in the Chinese population.
Data, including data from studies in knockout mice, suggest that the oxidative metabolism of 1,2-dichloropropane, a carcinogenic solvent/insecticide, is exclusively catalyzed by Cyp2e1; this biotransformation step is indispensable for manifestation of hepatotoxic effect of the solvent.
Taken together, these results suggested that 1,2-dichloroethane (1,2-DCE (show DHCR24 Antibodies)) could enhance CYP2E1 protein expression and enzymatic activity, which could cause oxidative damage in liver, serving as an important mechanism underlying 1,2-DCE (show DHCR24 Antibodies)-induced liver damage
CYP2E1 is important in causing aging-dependent hepatic steatosis, apoptosis and fibrosis possibly through increasing nitroxidative stress.
Our results support a significant role for CYP2E1 as a novel 4-Aminobiphenyl N-oxidizing enzyme in adult mice
Schisandrol B protects against APAP-induced liver injury, potentially through inhibition of CYP2E1/3A11-mediated APAP bioactivation and regulation of the p53 (show TP53 Antibodies), p21 (show D4S234E Antibodies), CCND1 (show CCND1 Antibodies), PCNA (show PCNA Antibodies), and BCL-2 (show BCL2 Antibodies) to promote liver regeneration.
Studied hepatic stellate cell cytoglobin (show CYGB Antibodies) involvement in acetaminophen induced hepatotoxicity through the regulation of CYP2E1.
Data suggest that expression of Cyp2e1 in adipose tissue can be regulated by dietary factors; here, expression of Cyp2e1 in white adipose tissue is down-regulated in obesity caused by high-fat diet.
The Cyp2e1-null mice displayed a susceptibility to lung toxicity of styrene similar to that of the wild-type animals; however, Cyp2f2-null mice were resistant to styrene-induced pulmonary toxicity.
significant increases in Col1a1 (show COL1A1 Antibodies), serine/threonine-protein kinase 1, Ctnnb1 (show CTNNB1 Antibodies), CSRNP1 (show CSRNP1 Antibodies), Ddit4 (show DDIT4 Antibodies), Cyp2e1, and Krit1 (show KRIT1 Antibodies) expressions and great decreases inreceptor D2, Neu1 (show NEURL Antibodies), and Dhcr7 (show DHCR7 Antibodies) expressions following long-term exposure to TiO2 NPs (show NPS Antibodies)
ATF4 (show ATF4 Antibodies) expression in the liver is responsible for the protective effects against high fat diet-induced CYP2E1 expression.
A highly significant association was found between variation in skatole levels and SNPs within the CYP2E1 gene on chromosome 14.
The relationship between a single nucleotide polymorphism of CYP2E1 and boar taint in pork from Belgian swine is reported.
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is induced by ethanol, the diabetic state, and starvation. The enzyme metabolizes both endogenous substrates, such as ethanol, acetone, and acetal, as well as exogenous substrates including benzene, carbon tetrachloride, ethylene glycol, and nitrosamines which are premutagens found in cigarette smoke. Due to its many substrates, this enzyme may be involved in such varied processes as gluconeogenesis, hepatic cirrhosis, diabetes, and cancer.
cytochrome P450 2E1
, 4-nitrophenol 2-hydroxylase
, Cytochrome P450 2E1
, Cytochrome P450 LM3A
, Cytochrome P450 isozyme 3A
, Cytochrome P450-ALC
, Cytochrome P450-J
, cytochrome P-450j
, cytochrome P450, subfamily IIE (ethanol-inducible), polypeptide 1
, cytochrome P450-J
, flavoprotein-linked monooxygenase
, microsomal monooxygenase
, xenobiotic monooxygenase
, cytochrome P450, 2e1, ethanol inducible
, cytochrome P450-ALC
, cytochrome P450 subfamily 2e1 (ethanol-inducible)
, cytochrome P450, subfamily 2E, polypeptide 1
, cytochrome P450RLM6
, cytochrome P-450-J
, cytochrome P450 CYP2E1